Keywords: phase, ii, ranolazine, data, published, cv, therapeutics

Phase II ranolazine data published

Article | 01 July 1999

Print This

CV Therapeutics' ranolazine has completed a Phase II trial whichdemonstrates the compound has efficacy in increasing exercise time in chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in